NCT05897528View on ClinicalTrials.gov

Insulin Regulation and Severity of Severe Acute Respiratory Syndrome COVID-19 Infection

CompletedOBSERVATIONAL
Enrollment

589

Participants

Timeline

Start Date

October 14, 2021

Primary Completion Date

December 30, 2022

Study Completion Date

December 30, 2022

Conditions
COVID-19Diabetes MellitusCOVID-19 PneumoniaCOVID-19 Respiratory Infection
Interventions
OTHER

No Intervention

Difference in outcomes in patients with COVID-19 diagnosis and diabetes mellitus groups

Trial Locations (1)

92324

Arrowhead Regional Medical Center, Colton

All Listed Sponsors
lead

Arrowhead Regional Medical Center

OTHER

NCT05897528 - Insulin Regulation and Severity of Severe Acute Respiratory Syndrome COVID-19 Infection | Biotech Hunter | Biotech Hunter